Search results: Sage Journals

Restricted accessCase reportFirst published October, 2025

Management and desensitization to Avelumab in anaphylaxis and metastatic urothelial carcinoma: A case report

Rosalaura Villarreal-González, Ana Karen Treviño-Morales, Diana Cadenas-García [...]

Journal of Oncology Pharmacy Practice

Restricted accessReview articleFirst published September, 2018

Avelumab: A Review of Its Application in Metastatic Merkel Cell Carcinoma

Jocelyn Joseph, Chrystia Zobniw, Jennifer Davis [...]

Annals of Pharmacotherapy

Open accessReview articleFirst published 2019

A review of avelumab in locally advanced and metastatic bladder cancer

Arpit Rao, Manish R. Patel

Therapeutic Advances in Urology

Open accessResearch articleFirst published January, 2025

Platinum-based chemotherapy rechallenge or enfortumab vedotin after maintenance avelumab or pembrolizumab for locally advanced or metastatic urothelial carcinoma

Nobutaka Nishimura, Makito Miyake, Norimi Takamatsu [...]

Bladder Cancer

Open accessResearch articleFirst published 2019

Immuno-PET Imaging of the Programmed Cell Death-1 Ligand (PD-L1) Using a Zirconium-89 Labeled Therapeutic Antibody,Avelumab

Elaine M. Jagoda, Olga Vasalatiy, Falguni Basuli [...]

Molecular Imaging

Open accessResearch articleFirst published 2025

Xevinapant plus avelumab in advanced solid tumours,with a dose expansion in advanced non-small-cell lung cancer: exploratory biomarker,safety and efficacy analyses from an open-label,nonrandomised phase Ib study

Glenwood Goss, Tudor Ciuleanu, Rodryg Ramlau [...]

Therapeutic Advances in Medical Oncology

Restricted accessResearch articleFirst published July, 2017

Drug Monographs: Avelumab and Ribociclib

J. Aubrey Waddell, Dominic A. Solimando

Hospital Pharmacy

Open accessReview articleFirst published 2023

The role of switch maintenance therapy in urothelial cancers

Eun-mi Yu, Mythri Mudireddy, Rakesh Biswas [...]

Therapeutic Advances in Urology

Restricted accessArticle commentaryFirst published January, 2019

Inferior outcomes in immunocompromised Merkel cell carcinoma patients: Can they be overcome by the use of PD1/PDL1 inhibitors?

Constantin A Dasanu, Michael Del Rosario, Ion Codreanu [...]

Journal of Oncology Pharmacy Practice

Restricted accessReview articleFirst published January, 2018

The Emerging Role of PD-1/PD-L1–Targeting Immunotherapy in the Treatment of Metastatic Urothelial Carcinoma

Morgan E. Gwynn, David L. DeRemer

Annals of Pharmacotherapy

Restricted accessCase reportFirst published October, 2025

Management and desensitization to Avelumab in anaphylaxis and metastatic urothelial carcinoma: A case report

Rosalaura Villarreal-González, Ana Karen Treviño-Morales, Diana Cadenas-García [...]

Journal of Oncology Pharmacy Practice

Restricted accessReview articleFirst published September, 2018

Avelumab: A Review of Its Application in Metastatic Merkel Cell Carcinoma

Jocelyn Joseph, Chrystia Zobniw, Jennifer Davis [...]

Annals of Pharmacotherapy

Open accessReview articleFirst published 2019

A review of avelumab in locally advanced and metastatic bladder cancer

Arpit Rao, Manish R. Patel

Therapeutic Advances in Urology

Open accessResearch articleFirst published January, 2025

Platinum-based chemotherapy rechallenge or enfortumab vedotin after maintenance avelumab or pembrolizumab for locally advanced or metastatic urothelial carcinoma

Nobutaka Nishimura, Makito Miyake, Norimi Takamatsu [...]

Bladder Cancer

Open accessResearch articleFirst published 2019

Immuno-PET Imaging of the Programmed Cell Death-1 Ligand (PD-L1) Using a Zirconium-89 Labeled Therapeutic Antibody,Avelumab

Elaine M. Jagoda, Olga Vasalatiy, Falguni Basuli [...]

Molecular Imaging

Open accessResearch articleFirst published 2025

Xevinapant plus avelumab in advanced solid tumours,with a dose expansion in advanced non-small-cell lung cancer: exploratory biomarker,safety and efficacy analyses from an open-label,nonrandomised phase Ib study

Glenwood Goss, Tudor Ciuleanu, Rodryg Ramlau [...]

Therapeutic Advances in Medical Oncology

Restricted accessResearch articleFirst published July, 2017

Drug Monographs: Avelumab and Ribociclib

J. Aubrey Waddell, Dominic A. Solimando

Hospital Pharmacy

Open accessReview articleFirst published 2023

The role of switch maintenance therapy in urothelial cancers

Eun-mi Yu, Mythri Mudireddy, Rakesh Biswas [...]

Therapeutic Advances in Urology

Restricted accessArticle commentaryFirst published January, 2019

Inferior outcomes in immunocompromised Merkel cell carcinoma patients: Can they be overcome by the use of PD1/PDL1 inhibitors?

Constantin A Dasanu, Michael Del Rosario, Ion Codreanu [...]

Journal of Oncology Pharmacy Practice

Restricted accessReview articleFirst published January, 2018

The Emerging Role of PD-1/PD-L1–Targeting Immunotherapy in the Treatment of Metastatic Urothelial Carcinoma

Morgan E. Gwynn, David L. DeRemer

Annals of Pharmacotherapy